Related Experiment Video
Updated: Jan 19, 2026
Cell Metabolism, Metabolic Pathways and Assays
Published on: April 30, 2023
MAIT cells in metabolic diseases
1Institut Cochin, CNRS, UMR8104, INSERM U1016, Université de Paris, Paris, France; Laboratoire d'Excellence Inflamex, Sorbonne Paris Cité, Paris, France; Master de Biologie, École Normale Supérieure de Lyon, Université Claude Bernard Lyon I, Université de Lyon, 69342, Lyon Cedex 07, France.
Background:
Metabolic diseases represent a wide category of alterations affecting metabolism. These pathologies are notably marked by inflammation that implicates the immune system. Mucosal Associated Invariant (MAI)T cells are immune cells expressing a semi-invariant TCR able to recognize bacterial and fungal vitamin B metabolites. MAIT cells can promote inflammation and are present in many organs central to metabolism, suggesting a role in the etiopathology of these diseases.
Scope Of The Review:
Here, we will review what is known of the involvement of MAIT cells in metabolic pathologies in humans and mice.
Major Conclusions:
MAIT cells are severely affected, overactivated with a frequency reduction and a phenotype shift from protective to deleterious. Therefore, they might be a novel target to treat, in particular, pancreas and liver metabolic diseases.
More Related Videos
Related Concept Videos
An Introduction to Cell Metabolism
07:03In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
What is Metabolism?
06:26Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
12:20Analysis of Hematopoietic Stem Progenitor Cell Metabolism

